Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

At this time, I would like to welcome everyone to the Dexcom Inc. fourth quarter 2024 earnings release conference call. All ...

While I would certainly agree that the microbes in fermented foods may provide health benefits, my view and that of other ...

In this Healio Video Perspective from Telling It Like It Is, Cynthia Matossian, MD, FACS, shared pearls for ophthalmologists ...

Nemluvio is the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling of IL-31, which drives itch and is involved in inflammation and skin barrier ...

Mariam F. Eskander, MD, MPH, and Coral O. Omene, MD, PhD, discuss how medical mistrust has impacted participation in oncology clinical trials.

Positve overall survival data could lead to a label expansion for Pfizer's combination to treat metastatic ...

In September 2024, 17 states including Arkansas joined a complaint against the United States Department of Health and Human ...

The recently re-elected President of the USA's decision to withdraw the USA from WHO is highly regrettable on multiple levels, and hopefully will be quickly reconsidered.1,2 But if it holds, it ...

Prediction is very difficult, especially about the future”; whether it is the Nobel laureate Niels Bohr or others who have ...